PFIZER INC Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax of -$763.00 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Income Statement › Other Income
us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax · last filed 2021-02-25
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for the quarter ending 2020-12-31 was $292.00M.
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for the quarter ending 2020-09-27 was -$1.18B.
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for the quarter ending 2020-06-28 was $153.00M, a 53.00% increase year-over-year.
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for the quarter ending 2020-03-29 was -$31.00M, a 183.78% decline year-over-year.
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2020 was -$763.00M.
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2019 was -$289.00M.
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2018 was -$153.00M, a 143.97% decline from fiscal 2017.
- PFIZER INC other comprehensive income (loss), defined benefit plan, gain (loss), after reclassification adjustment, before tax for fiscal 2017 was $348.00M.
| Period end | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax 3 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax 6 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax 9 month | Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax 12 month |
|---|---|---|---|---|
| 2020-12-31 | $292.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$885.00M derived: sum of 2 quarters · filed 2021-02-25 | -$732.00M derived: sum of 3 quarters · filed 2021-02-25 | -$763.00M 10-K · filed 2021-02-25 |
| 2020-09-27 | -$1.18B 10-Q · filed 2020-11-05 | -$1.02B derived: sum of 2 quarters · filed 2020-11-05 | -$1.05B 10-Q · filed 2020-11-05 | -$1.45B derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-06-28 | $153.00M 10-Q · filed 2020-08-06 | $122.00M 10-Q · filed 2020-08-06 | -$272.00M derived: sum of 3 quarters · filed 2021-02-25 | -$303.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-03-29 | -$31.00M 10-Q · filed 2020-05-07 | -$425.00M derived: sum of 2 quarters · filed 2021-02-25 | -$456.00M derived: sum of 3 quarters · filed 2021-02-25 | -$356.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | -$394.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$425.00M derived: sum of 2 quarters · filed 2021-02-25 | -$325.00M derived: sum of 3 quarters · filed 2021-02-25 | -$289.00M 10-K · filed 2021-02-25 |
| 2019-09-29 | -$31.00M 10-Q · filed 2020-11-05 | $69.00M derived: sum of 2 quarters · filed 2020-11-05 | $105.00M 10-Q · filed 2020-11-05 | -$521.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $100.00M 10-Q · filed 2020-08-06 | $137.00M 10-Q · filed 2020-08-06 | -$490.00M derived: sum of 3 quarters · filed 2021-02-25 | -$332.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $37.00M 10-Q · filed 2020-05-07 | -$590.00M derived: sum of 2 quarters · filed 2021-02-25 | -$432.00M derived: sum of 3 quarters · filed 2021-02-25 | -$291.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$627.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$469.00M derived: sum of 2 quarters · filed 2021-02-25 | -$328.00M derived: sum of 3 quarters · filed 2021-02-25 | -$153.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | $158.00M 10-Q · filed 2019-11-07 | $299.00M derived: sum of 2 quarters · filed 2019-11-07 | $474.00M 10-Q · filed 2019-11-07 | $438.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-07-01 | $141.00M 10-Q · filed 2019-08-08 | $316.00M 10-Q · filed 2019-08-08 | $280.00M derived: sum of 3 quarters · filed 2020-02-27 | $279.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-04-01 | $175.00M 10-Q · filed 2019-05-09 | $139.00M derived: sum of 2 quarters · filed 2020-02-27 | $138.00M derived: sum of 3 quarters · filed 2020-02-27 | $262.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$37.00M derived: sum of 2 quarters · filed 2020-02-27 | $87.00M derived: sum of 3 quarters · filed 2020-02-27 | $348.00M 10-K · filed 2020-02-27 |
| 2017-10-01 | -$1.00M 10-Q · filed 2018-11-08 | $123.00M derived: sum of 2 quarters · filed 2018-11-08 | $384.00M 10-Q · filed 2018-11-08 | -$1.07B derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-07-02 | $124.00M 10-Q · filed 2018-08-09 | $385.00M 10-Q · filed 2018-08-09 | -$1.07B derived: sum of 3 quarters · filed 2019-02-28 | -$913.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-04-02 | $261.00M 10-Q · filed 2018-05-10 | -$1.19B derived: sum of 2 quarters · filed 2019-02-28 | -$1.04B derived: sum of 3 quarters · filed 2019-02-28 | -$952.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$1.45B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$1.30B derived: sum of 2 quarters · filed 2019-02-28 | -$1.21B derived: sum of 3 quarters · filed 2019-02-28 | -$1.01B 10-K · filed 2019-02-28 |
| 2016-10-02 | $155.00M 10-Q · filed 2017-11-09 | $240.00M derived: sum of 2 quarters · filed 2017-11-09 | $444.00M 10-Q · filed 2017-11-09 | $1.32B derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-07-03 | $85.00M 10-Q · filed 2017-08-10 | $288.00M 10-Q · filed 2017-08-10 | $1.17B derived: sum of 3 quarters · filed 2018-02-22 | $1.19B derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-04-03 | $203.00M 10-Q · filed 2017-05-11 | $1.08B derived: sum of 2 quarters · filed 2018-02-22 | $1.10B derived: sum of 3 quarters · filed 2018-02-22 | $1.22B derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $877.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $900.00M derived: sum of 2 quarters · filed 2018-02-22 | $1.02B derived: sum of 3 quarters · filed 2018-02-22 | $1.38B 10-K · filed 2018-02-22 |
| 2015-09-27 | $23.00M 10-Q · filed 2016-11-10 | $141.00M derived: sum of 2 quarters · filed 2016-11-10 | $506.00M 10-Q · filed 2016-11-10 | -$3.42B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-28 | $118.00M 10-Q · filed 2016-08-11 | $483.00M 10-Q · filed 2016-08-11 | -$3.44B derived: sum of 3 quarters · filed 2017-02-23 | -$3.31B derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-29 | $365.00M 10-Q · filed 2016-05-12 | -$3.56B derived: sum of 2 quarters · filed 2017-02-23 | -$3.43B derived: sum of 3 quarters · filed 2017-02-23 | -$3.38B derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$3.92B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$3.80B derived: sum of 2 quarters · filed 2017-02-23 | -$3.75B derived: sum of 3 quarters · filed 2017-02-23 | -$3.69B 10-K · filed 2017-02-23 |
| 2014-09-28 | $127.00M 10-Q · filed 2015-11-05 | $174.00M derived: sum of 2 quarters · filed 2015-11-05 | $233.00M 10-Q · filed 2015-11-05 | $4.02B derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-29 | $47.00M 10-Q · filed 2015-08-06 | $106.00M 10-Q · filed 2015-08-06 | $3.89B derived: sum of 3 quarters · filed 2016-02-29 | $4.04B derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-30 | $59.00M 10-Q · filed 2015-05-07 | $3.85B derived: sum of 2 quarters · filed 2016-02-29 | $4.00B derived: sum of 3 quarters · filed 2016-02-29 | $4.25B derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $3.79B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.94B derived: sum of 2 quarters · filed 2016-02-29 | $4.19B derived: sum of 3 quarters · filed 2016-02-29 | $4.52B 10-K · filed 2016-02-29 |
| 2013-09-29 | $150.00M 10-Q · filed 2014-11-06 | $406.00M derived: sum of 2 quarters · filed 2014-11-06 | $731.00M 10-Q · filed 2014-11-06 | -$626.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $256.00M 10-Q · filed 2014-08-07 | $581.00M 10-Q · filed 2014-08-07 | -$776.00M derived: sum of 3 quarters · filed 2015-02-27 | -$731.00M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $325.00M 10-Q · filed 2014-05-08 | -$1.03B derived: sum of 2 quarters · filed 2015-02-27 | -$987.00M derived: sum of 3 quarters · filed 2015-02-27 | -$1.35B derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | -$1.36B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$1.31B derived: sum of 2 quarters · filed 2015-02-27 | -$1.67B derived: sum of 3 quarters · filed 2015-02-27 | -$1.42B 10-K · filed 2015-02-27 |
| 2012-09-30 | $45.00M 10-Q · filed 2013-11-08 | -$316.00M derived: sum of 2 quarters · filed 2013-11-08 | -$63.00M 10-Q · filed 2013-11-08 | -$2.29B derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-07-01 | -$361.00M 10-Q · filed 2013-08-09 | -$108.00M 10-Q · filed 2013-08-09 | -$2.33B derived: sum of 3 quarters · filed 2014-02-28 | -$2.20B derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-04-01 | $253.00M 10-Q · filed 2013-05-10 | -$1.97B derived: sum of 2 quarters · filed 2014-02-28 | -$1.84B derived: sum of 3 quarters · filed 2014-02-28 | -$1.70B derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | -$2.23B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$2.09B derived: sum of 2 quarters · filed 2014-02-28 | -$1.95B derived: sum of 3 quarters · filed 2014-02-28 | -$1.92B 10-K · filed 2014-02-28 |
| 2011-10-02 | $134.00M 10-Q · filed 2012-11-09 | $272.00M derived: sum of 2 quarters · filed 2012-11-09 | $306.00M 10-Q · filed 2012-11-09 | |
| 2011-07-03 | $138.00M 10-Q · filed 2012-08-09 | $172.00M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | -$810.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |